← Pharming Group N.V.
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Net Income | — | — | — | — | — | $13.7m |
($10.5m)
-177.14%
|
($11.8m)
-12.26%
|
$2.9m
+124.08%
|
$15.8m
+455.66%
|
|
| Net Income From Continuing Operations | — | — | — | — | — | $15.0m | ($12.0m) | ($8.5m) | $12.8m | $15.8m | |
| Adjustments For Depreciation And Amortisation Expense And Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | — | — | $5.2m | $7.3m | $19.6m | $13.2m | $15.9m | $16.1m | $11.2m | — | |
| Share of net losses (gains) in associates using the equity method | — | $0 | ($229k) | ($317k) | ($694k) | $1.1m | $289k | $1.8m | ($623k) | — | |
| Profit or Loss | — | — | $36.2m | $33.0m | $16.0m | $13.7m | ($10.5m) | ($11.8m) | $2.5m | — | |
| Other Adjustments To Reconcile Profit Loss | — | ($2.4m) | ($39k) | ($1.4m) | $524k | ($1.6m) | ($1.1m) | $0 | $0 | — | |
| Depreciation, amortization, impairment of non-current assets | — | $6.6m | $5.2m | $7.3m | $19.6m | $13.2m | $15.9m | $16.1m | $11.2m | $12.1m | |
| Adjustments For Deferred Tax Of Prior Periods | — | — | ($373k) | ($3.0m) | ($1.1m) | $124k | $73k | $1.8m | ($334k) | — | |
| Adjustments For Share-Based Payments | — | — | $3.8m | $5.7m | $9.1m | $6.4m | $9.3m | $11.2m | $13.8m | — | |
| Exercise of share-based compensation awards | — | $10.5m | $2.8m | $2.4m | $4.7m | $2.3m | $8.1m | $5.6m | $19.8m | — | |
| Investment accounted for using the equity method | — | $0 | ($2.5m) | ($288k) | $0 | — | $0 | $0 | ($739k) | — | |
| Earnings (Loss)es From Equity Investments | — | — | — | — | — | $1.1m | $289k | $1.8m | ($623k) | ($783k) | |
| Change In Working Capital | — | — | — | — | — | ($387k) | ($17.0m) | ($10.1m) | $10.4m | ($3.6m) | |
| Total changes in working capital | — | ($4.8m) | $721k | ($2.6m) | ($5.0m) | ($387k) | ($17.0m) | ($10.1m) | $10.4m | — | |
| Trade and other receivables | — | ($6.6m) | ($8.5m) | ($3.5m) | $5.9m | $2.4m | ($18.5m) | ($6.8m) | ($3.4m) | — | |
| Change In Receivables | — | — | — | — | — | $2.4m | ($18.5m) | ($6.8m) | ($3.4m) | ($4.4m) | |
| Inventories | — | $1.0m | $3.1m | ($2.8m) | ($6.2m) | ($15.0m) | ($14.4m) | ($503k) | ($1.3m) | ($4.5m) | |
| Change In Inventory | — | — | — | — | — | ($15.0m) | ($14.4m) | ($503k) | ($1.3m) | ($4.5m) | |
| Payables and other current liabilities | — | $1.4m | $8.7m | $2.6m | ($5.2m) | $12.0m | $16.2m | ($2.8m) | $14.1m | — | |
| Capital expenditure for property, plant and equipment | — | ($2.5m) | ($2.4m) | ($4.1m) | ($10.7m) | ($1.4m) | ($1.4m) | ($790k) | ($749k) | ($660k) | |
| Capital Expenditure Reported | — | — | — | $4.1m | $10.7m | ($1.4m) | ($1.4m) | ($790k) | ($749k) | ($660k) | |
| Adjustments For Gain Loss On Disposal Of Investments In Subsidiaries Joint Ventures And Associates | — | — | — | — | — | $12.2m | $0 | $0 | — | — | |
| Purchases of marketable securities | — | — | — | — | $0 | $0 | ($382.0m) | ($284.3m) | ($2k) | — | |
| Proceeds from sale of marketable securities | — | — | — | — | $0 | $0 | $232.8m | $314.6m | $85.0m | — | |
| Net Other Investing Changes | — | — | — | — | — | — | $21.3m | — | ($1k) | ($1k) | |
| Net cash flows generated from (used in) investing activities | — | ($3.8m) | ($25.2m) | ($13.7m) | ($21.3m) | $5.3m | ($129.4m) | $31.6m | $26.3m | — | |
| Proceeds From Borrowings Classified As Financing Activities | — | — | — | — | — | — | — | $104.5m | $0 | — | |
| Repayments Of Borrowings Classified As Financing Activities | — | — | $31.4m | $50.1m | $0 | $0 | — | — | — | — | |
| Issuance Of Debt | — | — | — | — | — | $0 | $0 | $104.5m | $0 | $0 | |
| Long Term Debt Issuance | — | — | — | — | — | $0 | $0 | $104.5m | $0 | $0 | |
| Net Issuance Payments Of Debt | — | — | — | — | — | ($3.3m) | ($4.0m) | ($34.4m) | ($4.2m) | ($16.4m) | |
| Net Long Term Debt Issuance | — | — | — | — | — | ($3.3m) | ($4.0m) | ($34.4m) | ($4.2m) | ($16.4m) | |
| Long Term Debt Payments | — | — | — | — | — | ($3.3m) | ($4.0m) | ($138.9m) | ($4.2m) | ($16.4m) | |
| Repayment Of Debt | — | — | — | — | — | ($3.3m) | ($4.0m) | ($138.9m) | ($4.2m) | ($16.4m) | |
| Issuance Of Capital Stock | — | — | — | — | $4.7m | $2.3m | — | — | — | $1.6m | |
| Common Stock Issuance | — | — | — | — | $4.7m | $2.3m | — | — | — | $1.6m | |
| Cash Dividends Paid | — | — | — | — | — | $0 | $0 | $0 | $0 | $0 | |
| Net Other Financing Charges | — | — | — | — | ($25.0m) | — | — | — | ($7.9m) | ($7.9m) | |
| Net cash flows generated from (used in) financing activities | — | ($18.0m) |
($56.6m)
-215.39%
|
$53.1m
+193.76%
|
($27.9m)
-152.62%
|
($5.0m)
+82.17%
|
($1.0m)
+79.14%
|
($34.4m)
-3212.03%
|
$1.5m
+104.34%
|
— | |
| Increase (decrease) of cash | — | $18.8m | ($15.4m) | $113.4m | ($11.4m) | $22.8m | ($147.7m) | ($4.6m) | $82.5m | — | |
| Beginning Cash Position | — | — | — | — | — | $191.9m | $207.3m | $61.7m | $54.9m | $92.1m | |
| Cash and cash equivalents at beginning of period | $58.7m | $80.3m | $66.3m | $167.1m | $191.9m | $207.3m | $61.7m | $54.9m | $145.3m | — | |
| Restricted cash | — | $132k | ($1.1m) | $1.0m | $467k | $273k | ($216k) | ($17k) | ($285k) | — | |
| Exchange rate effects | — | $2.9m | $1.3m | ($12.6m) | ($1.8m) | ($7.4m) | $2.1m | ($2.2m) | $7.9m | — | |
| Effect Of Exchange Rate Changes | — | — | — | — | — | ($7.4m) | $2.1m | ($2.2m) | $7.9m | ($698k) | |
| Additional Supplementary Disclosures | |||||||||||
| Additional Supplementary Disclosures | |||||||||||
| Additional Financial Items | |||||||||||
| Adjustments For Current Tax Of Prior Period | — | — | ($242k) | ($1.3m) | ($96k) | $9k | ($241k) | ($315k) | $765k | — | |
| Adjustments For Finance Costs | — | — | $15.3m | $29.2m | $6.2m | $5.5m | $9.1m | $9.9m | $17.9m | — | |
| Adjustments For Finance Income | — | — | $1.0m | $624k | $14.9m | $4.5m | $3.7m | $6.8m | $2.2m | — | |
| General And Administrative Expense | — | — | $18.9m | $21.1m | $37.0m | $46.0m | $55.9m | $70.7m | $80.0m | — | |
| Increase Decrease In Working Capital | — | — | ($721k) | $2.6m | $5.0m | $387k | $17.0m | $10.1m | ($10.4m) | ($3.6m) | |
| Interest Received Classified As Operating Activities | — | $18k | $1.0m | $626k | $53k | $85k | $2.9m | $5.2m | $2.1m | — | |
| Payments Of Lease Liabilities Classified As Financing Activities | — | — | $2.0m | $1.9m | $3.2m | $3.3m | $5.1m | $4.0m | $4.2m | — | |
| Profit (loss) before tax | — | $857k | $46.7m | $38.6m | $23.1m | $15.0m | ($12.0m) | ($8.5m) | $12.8m | — | |
| Equity settled share based payments | — | $3.3m | $3.8m | $5.7m | $9.1m | $6.4m | $9.3m | $11.2m | $13.8m | — | |
| Fair value loss (gain) on revaluation | — | $495k | $209k | ($60k) | ($114k) | $1.2m | $930k | ($5.0m) | ($2.3m) | — | |
| Gain on disposal from PRV sale | — | — | — | — | $0 | $0 | ($21.3m) | $0 | $0 | — | |
| Loss (gain) on disposal of leases | — | — | — | — | — | $0 | $0 | $22k | ($3.7m) | — | |
| Other finance income | — | ($18k) | ($1.0m) | ($624k) | ($14.9m) | ($4.5m) | ($3.7m) | ($6.8m) | ($2.2m) | — | |
| Other finance expenses | — | $36.7m | $15.3m | $29.2m | $6.2m | $5.5m | $9.1m | $9.9m | $17.9m | — | |
| Provisions | — | — | — | — | — | — | $0 | $0 | $1.2m | — | |
| Proceeds from PRV sale | — | — | — | — | $0 | $0 | $21.3m | $0 | $0 | — | |
| Investment intangible assets | — | ($1.3m) | ($1.6m) | ($7.9m) | ($3.4m) | ($601k) | ($27k) | ($6k) | ($6k) | — | |
| Disposal of investment designated as at FVOCI | — | — | — | — | — | $0 | $0 | $2.1m | $224k | — | |
| Acquisition of a subsidiary, net of cash acquired | — | — | — | — | — | — | $0 | $0 | ($57.5m) | — | |
| Payment of lease liabilities | — | $0 | ($2.0m) | ($1.9m) | ($3.2m) | ($3.3m) | ($5.1m) | ($4.0m) | ($4.2m) | — | |
| Interests on lease liabilities | — | — | — | — | — | $0 | ($1.1m) | ($1.1m) | ($1.1m) | — | |
| Net proceeds of issued convertible bonds | — | — | — | — | — | $0 | $0 | $104.5m | $0 | — | |
| Repurchase of convertible bonds | — | ($2.3m) | $0 | $0 | — | $0 | $0 | ($134.9m) | $0 | — | |
| Interests on convertible bonds | — | ($11.1m) | ($8.4m) | ($1.9m) | ($4.4m) | ($4.0m) | ($4.0m) | ($4.5m) | ($5.1m) | — | |
| Acquisition of non-controlling interests | — | — | — | — | — | — | $0 | $0 | ($7.9m) | — | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | — | ($5.0m) | ($1.0m) | ($34.4m) | $1.5m | ($697k) | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | — | $5.3m | ($129.4m) | $31.6m | $26.3m | ($85.2m) | |
| Change In Other Working Capital | — | — | — | — | — | $273k | ($216k) | ($17k) | $902k | $5.4m | |
| Change In Payable | — | — | — | — | — | $12.0m | $16.2m | ($2.8m) | $14.1m | ($64k) | |
| Changes In Cash | — | — | — | — | — | $22.8m | ($147.7m) | ($4.6m) | $82.5m | ($50.9m) | |
| End Cash Position | — | — | — | — | — | $207.3m | $61.7m | $54.9m | $145.3m | $41.2m | |
| Financing Cash Flow | — | — | — | — | — | ($5.0m) |
($1.0m)
+79.14%
|
($34.4m)
-3212.03%
|
$1.5m
+104.34%
|
($697k)
-146.62%
|
|
| Free Cash Flow | — | — | — | — | — | $20.5m | ($18.8m) | ($2.6m) | $54.0m | $34.4m | |
| Gain Loss On Investment Securities | — | — | — | — | — | $1.2m | $930k | ($5.0m) | ($2.3m) | ($2.3m) | |
| Gain Loss On Sale Of Business | — | — | — | — | — | ($12.2m) | $0 | $0 | — | $0 | |
| Gain Loss On Sale Of PPE | — | — | — | — | — | $0 | $0 | $22k | — | $26k | |
| Interest Received CFO | — | — | — | — | — | $85k | $2.9m | $5.2m | $2.1m | $2.1m | |
| Investing Cash Flow | — | — | — | — | — | $5.3m | ($129.4m) | $31.6m | $26.3m | ($85.2m) | |
| Net Business Purchase And Sale | — | — | — | — | — | $7.3m | $0 | $0 | ($58.2m) | ($310k) | |
| Net Intangibles Purchase And Sale | — | — | — | — | — | ($601k) | ($27k) | ($6k) | ($6k) | $0 | |
| Operating Gains Losses | — | — | — | — | — | ($11.2m) | ($21.0m) | $1.8m | ($4.4m) | ($4.5m) | |
| Other Non Cash Items | — | — | — | — | — | $587k | $5.3m | ($1.9m) | $13.4m | — | |
| Proceeds From Stock Option Exercised | — | — | — | — | — | $2.3m | $8.1m | $5.6m | $19.8m | $23.6m | |
| Purchase Of Business | — | — | — | — | $0 | — | $0 | $0 | ($58.2m) | ($310k) | |
| Purchase Of Intangibles | — | — | — | — | — | ($601k) | ($27k) | ($6k) | ($6k) | $0 | |
| Sale Of Business | — | — | — | — | — | $7.3m | $0 | $0 | — | $0 | |
| Stock Based Compensation | — | — | — | — | — | $6.4m | $9.3m | $11.2m | $13.8m | $14.3m | |
| Net Investment Purchase And Sale | — | — | — | — | — | $0 | ($149.2m) | $32.4m | $85.2m | ($84.3m) | |
| Purchase Of Investment | — | — | — | — | — | $0 | ($382.0m) | ($284.3m) | ($2k) | ($102.6m) | |
| Sale Of Investment | — | — | — | — | — | $0 | $232.8m | $316.7m | $85.2m | $18.4m | |
| Change In Cash Supplemental As Reported | — | — | — | — | — | $22.8m | ($147.7m) | ($4.6m) | $82.5m | — | |
| Interest Paid Classified As Financing Activities | — | — | $8.4m | $1.9m | $4.4m | $4.0m | $4.0m | $4.5m | $5.1m | — | |
| Income Taxes Paid Refund Classified As Operating Activities | — | ($1.4m) | $5.1m | $2.3m | $0 | $1.2m | $655k | $15.6m | $4.6m | — |